Primary Progressive Aphasia Clinical Trial
Official title:
A Single Arm Study of Resting State Functional Magnetic Resonance Imaging (Rs-fMRI)-Guided Theta Burst Stimulation (TBS) in Primary Progressive Aphasia (PPA)
Frontotemporal degeneration (FTD) is a non-Alzheimer's dementia that is the 2nd most common cause of dementia in the United States. FTD may present with focal language symptoms that are clinically described as primary progressive aphasia (PPA). There are two types of PPA associated with FTD-semantic variant primary progressive aphasia (SV-PPA) and nonfluent/agrammatic variant primary progressive aphasia (NFV-PPA). Both diseases are progressive neurodegenerative disease processes that compromise dominant hemisphere large scale brain network function, ultimately resulting in mutism. There are currently no FDA-approved treatments for PPA and management is mostly supportive. In combination with resting state functional MRI (rs-fMRI), transcranial magnetic stimulation (TMS) with intermittent theta burst stimulation (iTBS) offers a non-invasive alternative to pharmacotherapy in persons with PPA. In our prior studies of Alzheimer's disease (AD) and Lewy body Dementia (LBD) subjects, investigators have determined that the anterior temporal pole (area TGd and TGv) is an area that is commonly dysfunctional in dementia. The investigators have already embarked upon an fMRI guided study of iTBS in early stage Alzheimer's disease where subjects received a series of 5 treatments to distinct brain regions inclusive of area TGd. The investigators propose a case study of 3 PPA studies where rs-fMRI is applied to the large-scale language networks.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT04290988 -
Circuitry Assessment and Reinforcement Training Effects on Recovery
|
N/A | |
Recruiting |
NCT04957537 -
Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
|
N/A | |
Completed |
NCT04045990 -
Network Modulation in Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05443633 -
Enhancing Language Function in Aphasia
|
N/A | |
Recruiting |
NCT03887481 -
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
|
N/A | |
Completed |
NCT03728582 -
Rehabilitating and Decelerating Language Loss in Primary Progressive Aphasia With tDCS Plus Language Therapy
|
N/A | |
Completed |
NCT01465360 -
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
|
N/A | |
Completed |
NCT02541097 -
Preventing Language Decline in Dementia
|
N/A | |
Recruiting |
NCT00537004 -
Language in Primary Progressive Aphasia
|
||
Recruiting |
NCT05741853 -
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
|
N/A | |
Active, not recruiting |
NCT05742698 -
Nabilone for Agitation in Frontotemporal Dementia
|
Phase 2 | |
Completed |
NCT02439853 -
Communication Bridge Speech Therapy Research Study
|
N/A | |
Completed |
NCT01623284 -
PiB PET Scanning in Speech and Language Based Dementias
|
Phase 1 | |
Completed |
NCT04726527 -
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
|
||
Completed |
NCT03076671 -
More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
|
N/A | |
Completed |
NCT05537688 -
Identification of Graphic Markers of Neurocognitive Disorders (MG)
|
||
Completed |
NCT05525377 -
Better Living With Non-memory-led Dementia
|
N/A | |
Completed |
NCT02928848 -
Transcranial Direct Current Stimulation for Primary Progressive Aphasia
|
N/A | |
Completed |
NCT04939818 -
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders
|
||
Enrolling by invitation |
NCT05368350 -
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
|
Early Phase 1 |